VIGL - Vigil Neuroscience GAAP EPS of -$0.53 beats by $0.03
2023-11-07 08:41:43 ET
More on Vigil Neuroscience
- Vigil Neuroscience: Interesting Early Data, Wait For Phase 2
- Vigil Neuro rises as dosing starts in Phase 1 trial for Alzheimer’s drug
- Vigil Neuroscience study for Alzheimer's drug to proceed with FDA restrictions
- Seeking Alpha’s Quant Rating on Vigil Neuroscience
- Historical earnings data for Vigil Neuroscience
For further details see:
Vigil Neuroscience GAAP EPS of -$0.53 beats by $0.03